Japan, Sept. 16 -- PEGAVISION CORP has got intellectual property rights for 'CONTACT LENS CONTAINING PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING THE SAME.' Other related details are as follows:
Application Number: JP,2024-035641
Category (FI): A61P27/02,A61K31/4402,A61P29/00,A61K31/704,A61P37/08,G02C7/04
Stage: PROBLEM TO BE SOLVED: To provide a contact lens containing a pharmaceutical composition and a method of manufacturing the same.SOLUTION: A contact lens includes a lens body and a pharmaceutical composition. The lens body is formed by curing a lens material, the lens material includes a hydrophilic vinyl monomer, a cross-linking agent and a photoinitiator, and the hydrophilic vinyl monomer includes no N-vinylpyrrolidone. The pharmaceutical composition includes an antihistamine agent, an anti-inflammatory agent, or a combination thereof, and does not include a chondroitin sulfate, a chondroitin sulfate salt, a polyvinylpyrrolidone, or a combination thereof. Another contact lens also includes a lens body and a pharmaceutical composition. The lens body is formed by curing a lens material and the lens material includes a hydrophilic vinyl monomer, a cross-linking agent, a rotaxane molecule and a photoinitiator. The pharmaceutical composition includes an antihistamine agent, an anti-inflammatory agent, or a combination thereof.SELECTED DRAWING: Figure 1 (Grant)
Filing Date: March 8, 2024
Publication Date: Jan. 9, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
